Viewing Study NCT05574504

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 7:55 PM

Ignite Modification Date: 2025-12-27 @ 11:27 AM

Study NCT ID: NCT05574504

Status: WITHDRAWN

Last Update Posted: 2024-08-01

First Post: 2022-09-19

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy

Sponsor: AdventHealth

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module